The major participants operating in the North America Endoscopic Accessories market are Olympus Corporation (Japan), Fujifilm Holdings Corporation (Japan), Stryker (U.S.), Hoya Group (Japan), Karl Storz GmbH & Co. KG (Germany), Medovations, Inc. (U.S.), Endo-Technik (Germany), EndoChoice Holdings Inc. (U.S.), US Endoscopy (U.S.), Conmed (U.S.), Solos Endoscopy, Inc. (U.S.), and Medivators, Inc. (U.S.).
Ask for Discount @//www.kamistm.com/contact/5423785655-ask_for_discount.html
Key players of the endoscopic accessories market in North America are focusing on new product launches, mergers & acquisitions, agreements, investments, and expansions to increase their market share. For instance, in July 2014, Allscripts Healthcare Solutions, Inc. (U.S.) acquired Oasis Medical Solutions Limited (U.K.), which is a privately-held London-based patient administration system (PAS) and health informatics solution provider. The Oasis PAS system was developed over 18 years in partnership with numerous NHS trusts that provides direct, effective, and extensible administrative workflow across all venues of care. By integrating the Oasis PAS technology and the Allscripts Sunrise clinical platform, Allscripts would be able to deliver highly competitive, single-source offering for an innovative and advanced electronic patient record solution across the U.K.
Request a Quote @//www.kamistm.com/contact/5423785655-request_a_quote.html
To sustain via organic growth, the leading players of the market also focus holistically on mergers & acquisitions to better cater the end users. For instance, in January 2016, CONMED acquired privately held Surgiquest, Inc., which will become part of the ConMed Advanced Surgical business. SurgiQuest develops, manufactures, and markets the AirSeal System (AirSeal), the first integrated access management technology for use in laparoscopic and robotic procedures. Through this acquisition, the company will increase its product portfolio. Similarly, in December 2015, US Endoscopy acquired Gastroenterology Business Unit (GBU) of Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business. It is thus broadening its portfolio offering related to CO2 insufflation and biopsy collection.